Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis

Lancet Gastroenterol Hepatol.

Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC

doi: 10.1016/S2468-1253(20)30217-X.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

Aliment Pharmacol Ther.

Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, Zinsmeister AR, Talley NJ

doi: 10.1111/apt.15077.

ColonoscopyIrritable Bowel Syndrome (IBS) and Chronic Constipation

Prevalence and impact of self-reported irritable bowel symptoms in the general population

United European Gastroenterol J.

Van den Houte K, Carbone F, Pannemans J, Corsetti M, Fischler B, Piessevaux H, Tack J

doi: 10.1177/2050640618821804.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea

Clin Gastroenterol Hepatol.

Singh P, Lee HN, Rangan V, Ballou S, Lembo J, Katon J, McMahon C, Friedlander D, Iturrino J, Nee J, Lembo A

doi: 10.1016/j.cgh.2019.08.020.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome

Gastroenterology.

Simrén M, Törnblom H, Palsson OS, Van Oudenhove L, Whitehead WE, Tack J

doi: 10.1053/j.gastro.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study

Am J Gastroenterol.

Shah ED, Almario CV, Spiegel BM, Chey WD

doi: 10.14309/ajg.0000000000000502.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome

Aliment Pharmacol Ther.

Vijayvargiya P, Camilleri M, Burton D, Busciglio I, Lueke A, Donato LJ

doi: 10.1111/apt.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study

Minerva Gastroenterol Dietol.

Riva A, Giacomelli L, Togni S, Franceschi F, Eggenhoffner R, Zuccarini MC, Belcaro G

doi: 10.23736/S1121-421X.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

A microbial signature of psychological distress in irritable bowel syndrome

Psychosom Med.

Peter J, Fournier C, Durdevic M, Knoblich L, Keip B, Dejaco C, Trauner M, Moser G

doi: 10.1097/PSY.

Related content

Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

Prevalence and impact of self-reported irritable bowel symptoms in the general population

Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea

Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome

Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study

Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome

Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: a randomized clinical study

A microbial signature of psychological distress in irritable bowel syndrome